Emodin has been observed to block the SARS-CoV-1 spike protein-ACE2 interaction and hence it appears to potentially have multiple routes to reduce COVID-19, if it also targets this interaction in SARS-CoV-255. The gene discussed is ACE2; the disease is COVID-19.